Canada Spends Logo

Explore our Budget 2026 analysis

Grant: Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships

McMaster University

$105,000.00

The DIalysis Symptom Control (DISCO) Trial: a 2x2 factorial pilot randomized placebo controlled trial of pramipexole and gabapentin for restless legs syndrome in hemodialysis

FY 2017-18

Summary
Patients with kidney disease are often excluded from research studies examining new interventions because of their kidney dysfunction. This puts them at a disadvantage despite commonly having other illnesses independent of their kidney disease. High quality studies are needed to answer questions relevant to patients with kidney disease and their caregivers with randomized clinical trials, the type of studies which are my area of focus, being one of the highest of levels of evidence to guide clinical decision-making. Symptoms are common in dialysis patients but are not optimally managed despite being a patient, caregiver and physician research priority. Restless legs syndrome (RLS) is a disorder of the nervous system that causes an uncontrollable urge to move your legs or other body parts that affects 30% dialysis patients and is bothersome, disrupts sleep and decreases quality of life. In patients without kidney disease, there is a significant amount of research dedicated to treating this condition but in individuals with kidney disease, in which the disorder is thought to be different in its origins, only a handful of clinical trials have been performed, and each of them with limitations. My research focuses on treating symptoms in dialysis patients so that they can feel better and have a better quality of life. I will be performing a pilot clinical trial of two different types of medications and their combination compared to placebo(s) (pills that look, smell, taste and feel the same as real drugs but do not contain any medication) for RLS in dialysis patients to see if it is feasible to expand to a larger study. This larger study will include multiple sites across Canada with the goal finding out the best way to control symptoms in this challenging condition.
Program
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Location
Ontario, Canada
Recipient Type
Academia
Type
Grant
Source
CIHR Funding Decisions Database

As published

Id
383297
Name
Collister David
Region
Ontario
Country
Canada
Orgtype
Institution Paid; Research Institution
Instname2
Circulatory and Respiratory Health
Theme2
Clinical
Prcname2
Doctoral Research Awards - B
Projecttitle
The DIalysis Symptom Control (DISCO) Trial: a 2x2 factorial pilot randomized placebo controlled trial of pramipexole and gabapentin for restless legs syndrome in hemodialysis
Programtype2
Studentship Programs
Orgnameinp2
McMaster University
Cihramount2
$105,000
Cihrequipment2
$0
Programname2
Doctoral Award - Frederick Banting and Charles Best Canada Graduate Scholarships
Keyworddelim
Hemodialysis; Minimal Clinically Important Difference; Patient Reported Outcomes; Placebo; Randomized Controlled Trial; Restless Legs Syndrome; Run-In Period; Symptoms
Abstract
Patients with kidney disease are often excluded from research studies examining new interventions because of their kidney dysfunction. This puts them at a disadvantage despite commonly having other illnesses independent of their kidney disease. High quality studies are needed to answer questions relevant to patients with kidney disease and their caregivers with randomized clinical trials, the type of studies which are my area of focus, being one of the highest of levels of evidence to guide clinical decision-making. Symptoms are common in dialysis patients but are not optimally managed despite being a patient, caregiver and physician research priority. Restless legs syndrome (RLS) is a disorder of the nervous system that causes an uncontrollable urge to move your legs or other body parts that affects 30% dialysis patients and is bothersome, disrupts sleep and decreases quality of life. In patients without kidney disease, there is a significant amount of research dedicated to treating this condition but in individuals with kidney disease, in which the disorder is thought to be different in its origins, only a handful of clinical trials have been performed, and each of them with limitations. My research focuses on treating symptoms in dialysis patients so that they can feel better and have a better quality of life. I will be performing a pilot clinical trial of two different types of medications and their combination compared to placebo(s) (pills that look, smell, taste and feel the same as real drugs but do not contain any medication) for RLS in dialysis patients to see if it is feasible to expand to a larger study. This larger study will include multiple sites across Canada with the goal finding out the best way to control symptoms in this challenging condition.
Competitiondate
201710
Approvedterm2
3 yrs 0 mth
Pinamesdelim
Collister, David
Approvedterm
3 ans 0 mois
Cihrcontribution2
~ $105,000~ $0~
McMaster University - $105,000 Grant (2017-18) | Canada Spends